YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQSX9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,182
Award facts
- Contract value 100% obligated
- $25,181.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,181.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The contract, designated as delivery order 4570613375, carries an ultimate completion date of February 11, 2026, and was awarded on January 21, 2026 without a set-aside designation. DMS Pharmaceutical Group will fulfill this order directly with no identified subcontractors, leveraging its established position as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and awarded in November 2025, positions DMS Pharmaceutical Group as a regional prime vendor contractor and authorizes DLA to issue multiple firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQSX9?
SPE2DR26FQSX9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FQSX9 worth?
The government has obligated $25,182 on SPE2DR26FQSX9.
Is contract SPE2DR26FQSX9 an order under another contract?
Yes. SPE2DR26FQSX9 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSX9 competed?
The extent of competition for SPE2DR26FQSX9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award